Journal
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 30, Issue 8, Pages 786-789Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/598345
Keywords
-
Funding
- Pfizer pharmaceutical company
Ask authors/readers for more resources
Knowledge of the prevalence rates and associated risk markers of vancomycin-resistant enterococci (VRE) colonization among long-term care facility (LTCF) residents could be used to improve screening policies among newly admitted hospital inpatients. In a cross-sectional survey among 1,215 residents of LTCFs in Jerusalem, the VRE carriage rate was 9.6%. Previous hospitalization and antibiotic treatment were associated with elevated VRE colonization rate. In contrast, moderate and severe levels of dependency and prolonged stay in an LTCF were associated with a decrease in the VRE colonization rate.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available